Cancer Biology T32 Predoctoral Training Program

To ensure successful careers, PhD scientists will need an acute awareness of rapidly evolving technologic approaches used in cancer biology research, deep knowledge of specific areas and critical thinking skills.

Emory University's Cancer Biology Predoctoral Training Program addresses the need for well-trained, diverse, cross-disciplinary PhD scientists entering the workforce. The program provides exceptional interdisciplinary training that is above and beyond PhD programs at Emory with opportunities for basic and translational research focused on cancer biology. Our training is integrated within the prestigious Winship Cancer Institute, a National Cancer Institute (NCI)-designated Comprehensive Cancer Center. A suite of evidence-based learning approaches, experienced research mentors who focus on cancer in various PhD Programs and unique ability to interact across clinical and laboratory disciplines enable development of our trainees success in academic-, industry- and government-based research careers.

The objective is to provide a diverse population of predoctoral students with effective training that culminates in:

• Developing PhD scientists with a deep understanding of cancer biology and critical thinking skills
• Training a workforce capable of conducting responsible and reproducible scientific studies
• Equipping students with the ability to communicate across disciplines and apply research findings in clinical settings

To achieve this goal, we use a core curriculum that includes discussion-based, active learning approaches to fundamental principles of cancer biology and development of presentation skills through didactic classroom and seminar experiences. The importance of rigor and reproducibility in cancer research is emphasized during all phases of the training for both students and mentors, with a required course as well as emphasizing this training as part of the courses, seminars and journal clubs.

Our program fosters a collaborative and inclusive environment, encouraging close interaction between PhD trainees and post-doctoral fellows in both clinical and research settings. This interaction enhances translational relevance in cancer research and communication.

The application process for the current cycle is closed.